Delivery Order SPE2DB20D3103-SPE2DB25FN5Z2
Award Date
4/25/25
Potential Completion Date
4/28/25
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,738.72, is for the supply of Humira (adalimumab) medication, a biologic drug used to treat autoimmune diseases. The contract is a firm-fixed-price, non-set-aside award with a period of performance through April 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Humira (adalimumab) medication. The contract has a ceiling value of $6,807.32 and is a firm-fixed price delivery order. It was awarded on August 27, 2024 with an ultimate completion date of August 28, 2024. The contract is not set aside for any special program. AmerisourceBergen, a major pharmaceutical distributor, will deliver the Humira medication to support the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $93,641.68, is for the supply of Humira (adalimumab) medication. It is a firm fixed-price delivery order contract with a completion date of February 28, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Humira (CF) 40 mg/0.4 mL medication, with a ceiling value of $5,811.50 and a performance period through April 2025. The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humira (adalimumab) medication, a brand-name biologic drug used to treat various autoimmune conditions. The contract has a firm fixed price of $3,055.11 and a period of performance through April 2025. It is not designated as a set-aside contract, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,622.88 firm fixed-price contract is for the supply of Humira (adalimumab) 40 mg/0.4 mL syringes, a biologic medication used to treat various autoimmune conditions. This contract is a delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a broad range of...
This is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the specialty medication Humira (adalimumab) at a firm fixed price of $3,002.48. The contract has an ultimate completion date of January 3, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) medication. The contract has a firm fixed price of $3,647.40 and a performance period ending on April 9, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) 80 mg/0.8 mL injectable medication. The contract has a firm fixed price of $3,694.32 and an ultimate completion date of August 1, 2024. This order is part of a larger Indefinite Delivery Contract between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,127.53, is for the supply of HUMIRA(CF) 40 MG/0.4 ML syringes, a medication used to treat various autoimmune conditions. The contract has an ultimate completion date of April 24, 2025. AmerisourceBergen Drug Corp is a significant vendor for the DLA, holding a $999,999,999.00 Indefinite Delivery Contract...